🇺🇸 Parnate in United States

FDA authorised Parnate on 21 February 1961

Marketing authorisations

FDA — authorised 21 February 1961

  • Application: NDA012342
  • Marketing authorisation holder: ADVANZ PHARMA
  • Status: supplemented

FDA

  • Status: approved

Parnate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Parnate approved in United States?

Yes. FDA authorised it on 21 February 1961; FDA has authorised it.

Who is the marketing authorisation holder for Parnate in United States?

ADVANZ PHARMA holds the US marketing authorisation.